<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04383821</url>
  </required_header>
  <id_info>
    <org_study_id>DTM-002</org_study_id>
    <nct_id>NCT04383821</nct_id>
  </id_info>
  <brief_title>Comparison of the Non-rebreather Mask With the Double-trunk Mask</brief_title>
  <official_title>Comparison of the Effects of Two Oxygen Delivery Systems on Arterial Blood Gases: Non-rebreather Mask Versus Double-trunk Mask</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the impact of the Double-Trunk Mask (DTM) with the Non-Rebreather
      Mask (NRM) on the blood gases of patients with severe hypoxemia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Double-Trunk Mask (DTM) is a device designed to increase the fraction of inspired oxygen
      in patients who receive oxygen therapy. The mask is composed of a regular aerosol mask with
      corrugated tubing (15 cm length) inserted into two lateral holes.

      Each included patient will wear the standard Non-Rebreather Mask (NRM) which is the standard
      delivery oxygen system for patients with acute severe hypoxemia. Then the patients will wear
      the DTM for 30 minutes. Finally the DTM will be replaced by the NRM for the next 30 minutes.
      The impact of both oxygen delivery system will be assessed by measuring the change of blood
      gases with each system.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 11, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in PaO2</measure>
    <time_frame>At baseline and 30 minutes after wearing DTM</time_frame>
    <description>Oxygen tension (PaO2) in mmHg will be analyzed from a sample taken from the arterial system</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in PaCO2</measure>
    <time_frame>At baseline and 30 minutes after wearing DTM</time_frame>
    <description>Carbon dioxide tension (PaCO2) in mmHg will be analyzed from a sample taken from the arterial system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in pH</measure>
    <time_frame>At baseline and 30 minutes after wearing DTM</time_frame>
    <description>Potential of Hydrogen (pH) will be analyzed from a sample taken from the arterial system.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in respiratory rate</measure>
    <time_frame>At baseline and 30 minutes after wearing both systems</time_frame>
    <description>Respiratory rate is measured during one minute by visual inspection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comfort with the oxygen delivery systems</measure>
    <time_frame>30 minutes after wearing both systems</time_frame>
    <description>A Likert scale from -5 to +5 will be used to measure the subjective comfort of the patient while wearing both oxygen delivery systems</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea with the oxygen delivery systems</measure>
    <time_frame>30 minutes after wearing both systems</time_frame>
    <description>A Visual Analogic Scale 0 to 10 will be used to measure the dyspnea of the patient while wearing both oxygen delivery systems</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Hypoxemia</condition>
  <arm_group>
    <arm_group_label>Double-Trunk Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The oxygen delivery system is the DTM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Rebreather Mask</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The oxygen delivery system is the NRM</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Double-Trunk Mask</intervention_name>
    <description>The DTM (oxygen delivery system) is worn by the patient for 30 minutes.</description>
    <arm_group_label>Double-Trunk Mask</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-Rebreather mask</intervention_name>
    <description>The NRM (standard oxygen delivery system) is worn by the patient for 30 minutes.</description>
    <arm_group_label>Non-Rebreather Mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        • Acute hypoxemia not corrected with nasal cannula

        Exclusion Criteria:

          -  Chronic obstructive pulmonary disease or other chronic respiratory disease

          -  Confusion

          -  Contra-indications to arterial blood gas sampling (peripheral arteriopathy, bleeding
             disorder)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>William Poncin, PT, PhD</last_name>
    <phone>+3227642316</phone>
    <email>william.poncin@uclouvain.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cliniques universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <state>Brussels Capital</state>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 7, 2020</study_first_submitted>
  <study_first_submitted_qc>May 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>May 7, 2020</last_update_submitted>
  <last_update_submitted_qc>May 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</investigator_affiliation>
    <investigator_full_name>Poncin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

